Scientists prevent cerebral palsy-like brain damage in mice
November 1, 2011 by admin · Leave a Comment
Scientists at Washington University School of Medicine in St. Louis have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy.
Using a mouse model that mimics the devastating condition in newborns, the researchers found that high levels of the protective protein, Nmnat1, substantially reduce damage that develops when the brain is deprived of oxygen and blood flow. The finding offers a potential new strategy for treating cerebral palsy as well as strokes, and perhaps Alzheimer’s, Parkinson’s and other neurodegenerative diseases. The research is reported online in the Proceedings of the National Academy of Sciences.
Study finds magnesium sulfate may offer protection from cerebral palsy
February 9, 2011 by admin · Leave a Comment
SAN FRANCISCO (February 10, 2011) In a study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting , in San Francisco, researchers will present findings that showed that in rats, the use of magnesium sulfate (Mg) significantly reduced the neonatal brain injury associated with maternal inflammation or maternal infection.
Babies born past term associated with increased risk of cerebral palsy
August 30, 2010 by admin · Leave a Comment
While preterm birth is a known risk factor for cerebral palsy, an examination of data for infants born at term or later finds that compared with delivery at 40 weeks, birth at 37 or 38 weeks or at 42 weeks or later was associated with an increased risk of cerebral palsy, according to a study in the September 1 issue of JAMA.
Cell transplants may benefit children with cerebral palsy
April 18, 2010 by admin · Leave a Comment
Contact: David Eve
celltransplantation@gmail.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Tampa, Fla. (April 19, 2010) A unique cell type that supports and surrounds (ensheathes) neurons within the nose (olfactory system) known as olfactory ensheathing cells (OECs), possess the ability to regenerate, are relatively easy to obtain, and have become prime candidates for transplantation to repair a number of lesions in the central nervous system (CNS). Transplanted OECs, known to retain exceptional plasticity and promote olfactory blood vessel growth while offering neuroprotection, have been demonstrated to be potentially useful for a number of neurological disorders, including multiple sclerosis, spinal cord injury and amyotrophc lateral sclerosis (ALS).
Incidence of cerebal palsy on rise in United States
February 7, 2010 by admin · Leave a Comment
Contact: Nora Plunkett
nplunkett@lumc.edu
708-216-6268
Loyola University Health System Read more
Bell’s palsy: Study calls for rethink of cause and treatment
October 6, 2009 by admin · Leave a Comment
Drugs widely prescribed to treat facial paralysis in Bell’s palsy are ineffective and are based on false notions of the cause of the condition, according to Cochrane Researchers. They say research must now focus on discovering other potential causes and treatments.
Debate on admin. of magnesium sulfate to pregnant women to prevent cerebral palsy in pre-term infants
June 29, 2009 by admin · Leave a Comment
June issue of American Journal of Obstetrics and Gynecology explores topic
New York, New York, June 29, 2009 – Cerebral palsy (CP) is the most prevalent chronic childhood motor disability with an estimated lifetime cost of nearly $1 million per individual. There is evidence that magnesium sulfate (MgSO4) can reduce the incidence of CP for very early preterm infants. Many thousands of pregnant women and their fetuses are exposed to MgSO4 every year in the United States for a variety of indications, and most obstetricians are comfortable with its use. Yet, there is still some controversy over whether magnesium sulfate is truly protective against CP. In three articles published in the June 2009 issue of the American Journal of Obstetrics & Gynecology, the authors shed some light on the debate.
Compounds may protect against cerebral palsy
February 25, 2009 by admin · Leave a Comment
Chemists at Northwestern University in Evanston, Ill., say two compounds they developed may be effective in protecting against cerebral palsy.
“The results were just stunning, absolutely amazing,” study leader Richard B. Silverman said in a statement. “There was a remarkable difference between animals treated with a small dose of one of our compounds and those that were not.”
Study finds magnesium prevents cerebral palsy
August 29, 2008 by admin · Leave a Comment
Doctors still can’t definitively say how it helps, but they know that magnesium given to pregnant women before they deliver prematurely cuts down on the chances of their baby developing cerebral palsy.
Multiple corticosteroid injections in pregnant women may increase cerebral palsy
September 21, 2007 by admin · Leave a Comment
When pregnant women are at high risk for preterm birth, giving them a single injection of corticosteroids has been shown to reduce the baby’s chances of having serious lung problems after birth.
But some women receive multiple injections of corticosteroids, and a new study shows that repeat courses of corticosteroids are linked to an increased rate of cerebral palsy among children of these mothers.



